China Optimizes Medical Insurance Policies for COVID-19 Treatment
The National Healthcare Security Administration (NHSA), Ministry of Finance, National Health Commission, and Chinese Center...
NHSA (prev. SMIA)
Pfizer’s Paxlovid Excluded from China’s NRDL Amid Price Dispute
The National Reimbursement Drug List (NRDL) negotiations have concluded, with Pfizer’s (NYSE: PFE) COVID-19 therapy...
NHSA and CNIPA Issue Opinions on Strengthening IP Protection in Drug Procurement
The National Healthcare Security Administration (NHSA) and the China National Intellectual Property Administration (CNIPA) have...
NHSA Orders Investigation into Unreasonable Medical Insurance Restrictions
The National Healthcare Security Administration (NHSA) has released a notification to medical insurance departments across...
NHSA Delays NRDL Negotiations Due to COVID-19 Disruptions
The National Healthcare Security Administration (NHSA) announced that it has been decided to delay the...
NHSA Responds to Proposal on Dental Implants’ Inclusion in NRDL
The National Healthcare Security Administration (NHSA) has responded to the No. 6184 suggestion from the...
NHSA Completes Expert Review for NRDL Price Negotiation Process
The National Healthcare Security Administration (NHSA) has released a notification indicating that the expert review...
NHSA Releases Guide on Volume-Based Procurement Drug Equivalents
The National Healthcare Security Administration (NHSA) has reportedly released a reference guide for industry players,...
NHSA Launches Expert Review for 2025 NRDL Update in China
The National Healthcare Security Administration (NHSA) announced on September 16 the commencement of the expert...
National High-Value Medical Consumables VBP Round Targets Orthopedic Spine Products
The national high-value medical consumables joint procurement office released a set of guiding opinions on...
NHSA Issues Notice on Special Treatment of Oral Implant Medical Service Charges
The National Healthcare Security Administration (NHSA) has released a Notice on “Carrying out Special Treatment...
NHSA Reveals Drugs Passing Initial Review for NRDL Inclusion
The National Healthcare Security Administration (NHSA) released a notification listing the drugs that have passed...
Beijing Adjusts UEBMI Account Management, Boosting Outpatient Coverage
The Beijing Municipal Medical Insurance Bureau has adjusted the management of Urban Employee Basic Medical...
China’s Health Commission Promotes Medical-Elderly Care Integration
China’s National Health Commission (NHC), National Development and Reform Commission (NDRC), and National Healthcare Security...
NHSA Proposes Regulations to Standardize Oral Implant Charges and Reduce Costs
The National Healthcare Security Administration (NHSA) has released a draft proposal titled “Notice on Carrying...
China Ramps Up Monitoring of Clinically Shortage Drugs Involving 109 Varieties
The Ministry of Industry and Information Technology (MIIT), National Health Commission (NHC), National Healthcare Security...
NHSA Cracks Down on Price Gouging in Basic Medical Insurance Scheme
The National Healthcare Security Administration (NHSA) has announced the results of a special investigation, revealing...
NHSA Issues New Medical Service Pricing Policy to Enhance Public Welfare and Innovation
The National Healthcare Security Administration (NHSA) has released a new notification on medical service pricing...
China’s 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids
China’s 7th national volume-based procurement (VBP) round concluded with winning bids averaging a 65.5% price...
NHSA Sets 2022 Goals for Basic Medical Insurance Funding and Reforms
The National Healthcare Security Administration (NHSA), Ministry of Finance (MOF), and State Taxation Administration (STA)...